The American Hospital Association Awards Exclusive Endorsement to Walgreens WellTransitions® Program for Medication Adherence
Program Assists Hospitals in Reducing Avoidable Readmissions
Chicago, IL (PRWEB) September 19, 2013
The American Hospital Association (AHA) today announced its exclusive endorsement of Walgreens WellTransitions®, recognizing the program for medication adherence. The innovative, coordinated care program aimed at improving medication adherence has demonstrated reductions in hospital readmission rates by helping patients better understand prescription therapies during and after discharge.
AHA Solutions, Inc., a subsidiary of the association, awards the exclusive AHA Endorsement to products and services that best support hospitals and health care organizations. After conducting the proprietary AHA Signature Due Diligence ProcessTM, AHA Solutions selected Walgreens WellTransitions program for its leadership in assisting hospitals in reducing avoidable readmissions by improving patients’ adherence to medication treatment plans after they are discharged. This is critical, as hospitals are working to improve outcomes by reducing avoidable patient readmission rates.
WellTransitions takes a comprehensive approach to reducing readmission rates by working with patients from the time they are admitted to the hospital through their discharge and return home. The program supports patient recovery through several hospital-to-home transition steps designed to improve wellness and reduce readmission rates while increasing patient satisfaction and lowering overall care costs.
“The Walgreens WellTransitions program will serve as another tool for hospitals seeking to reduce readmissions and support overall community wellness,” said Anthony J. Burke, president and CEO of AHA Solutions. “We have endorsed this program for the broad scope of services that are provided through Walgreens extensive network of pharmacies and pharmacy services. Walgreens has consistently demonstrated its long-term commitment to supporting hospitals’ efforts to extend patient care further into their communities.”
“Through WellTransitions, Walgreens pharmacy staff works closely with the hospital team to improve the transition of patients to their homes by educating and encouraging them to take their medications as prescribed,” said Joel Wright, Walgreens group vice president, enterprise specialty. “We’re proud to be recognized by the AHA for the program’s overall success, and the impact WellTransitions is having on overall patient health. Medication non-adherence is a significant contributor to preventable readmissions, and by providing this level of personalized care, we can play an important role in helping more people get, stay and live well.”
Early results indicate that WellTransitions has been instrumental in helping to reduce patient readmissions. Within the first six months after the program’s implementation at five hospitals, WellTransitions patients had a 9.4 percent unadjusted rate of 30-day readmission, compared to a 14.3 percent 30-day readmission rate for patients eligible for but not participating in the program.* A formal research study is planned to systematically evaluate the program’s effect on hospital readmissions rates.
To date, more than 15 hospitals have implemented the WellTransitions program since its inception in 2012. It is currently being rolled out at a growing number of other facilities throughout the U.S., including a growing number of the more than 170 hospitals where Walgreens operates an outpatient pharmacy.
- Walgreens clients’ data on file
About the AHA
The American Hospital Association (AHA) is a not-for-profit association of health care provider organizations and individuals that are committed to the improvement of health in their communities. The AHA is the national advocate for its members, who include nearly 5,000 member hospitals, health systems and other health care organizations and 43,000 individual members. Founded in 1898, the AHA provides education for health care leaders and is a source of information on health care issues and trends. Visit http://www.aha.org to learn more.
About AHA Solutions
AHA Solutions, Inc. is a resource to hospitals pursuing operational excellence. As a subsidiary of the AHA, AHA Solutions collaborates with hospital leaders to identify key challenges the health care field faces. After conducting the proprietary AHA Signature Due Diligence Process™, we award the exclusive AHA Endorsement. As an AHA member service, AHA Solutions provides access to content experts and education to support product decision making, and convenes people with like interests for knowledge sharing that is centered on timely information and research.
AHA Solutions is proud to reinvest its profits in the AHA Mission: To advance the health of individuals and communities. For more information, contact AHA Solutions at 800.242.4677 or visit http://www.aha-solutions.org.
As the nation's largest drugstore chain with fiscal 2012 sales of $72 billion, Walgreens (http://www.walgreens.com) vision is to be the first choice in health and daily living for everyone in America, and beyond. Each day, Walgreens provides more than 6 million customers the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice in communities across America. Walgreens scope of pharmacy services includes retail, specialty, infusion, medical facility and mail service, along with respiratory services. These services improve health outcomes and lower costs for payers including employers, managed care organizations, health systems, pharmacy benefit managers and the public sector. The company operates 8,117 drugstores in all 50 states, the District of Columbia and Puerto Rico. Take Care Health Systems is a Walgreens subsidiary that is the largest and most comprehensive manager of worksite health and wellness centers, medical practices, and in-store convenient care clinics, with more than 700 locations throughout the country.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/9/prweb11117857.htm